학술논문
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach.
Document Type
Journal Article
Source
Subject
Language
ISSN
0007-0920
Abstract
Emerging studies have demonstrated the potential of PI3Kδ blockade as an immunotherapy for solid tumours. In pre-clinical models, we recently demonstrated that anti-LAG3 immune checkpoint blockade vastly potentiated PI3Kδ-based immunotherapy, enabling successful tumour control in all treated mice. [ABSTRACT FROM AUTHOR]